Cobimetinib combined with vemurafenib in advanced BRAFV600 -mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Ascierto, Paolo A, MD, McArthur, Grant A, Prof, Dréno, Brigitte, Prof, Atkinson, Victoria, MD, Liszkay, Gabrielle, MD, Di Giacomo, Anna Maria, MD, Mandalà, Mario, MD, Demidov, Lev, MD, Stroyakovskiy, Daniil, MD, Thomas, Luc, Prof, de la Cruz-Merino, Luis, MD, Dutriaux, Caroline, MD, Garbe, Claus, Prof, Yan, Yibing, PhD, Wongchenko, Matthew, BS, Chang, Ilsung, PhD, Hsu, Jessie J, PhD, Koralek, Daniel O, PhD, Rooney, Isabelle, MBChB, Ribas, Antoni, Prof, Larkin, James, FRCP
Published in The lancet oncology (01.09.2016)
Published in The lancet oncology (01.09.2016)
Get full text
Journal Article